PE(15:0/20:0)

PE(15:0/20:0) is a lipid of Glycerophospholipids (GP) class. Pe(15:0/20:0) is associated with abnormalities such as Exanthema, Infection, Painful Bladder Syndrome, Obesity and Fatty Liver. The involved functions are known as conjugation, Transcription, Genetic, Sinking, Autophagy and Protein Biosynthesis. Pe(15:0/20:0) often locates in membrane fraction, soluble, Membrane, Body tissue and Tissue membrane. The associated genes with PE(15:0/20:0) are GABARAPL2 gene, ATG10 gene, ATG12 gene, SLC33A1 gene and GABARAP gene. The related lipids are Liposomes, Lipopolysaccharides, Phosphatidylserines, Membrane Lipids and Cardiolipins. The related experimental models are Knock-out and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of PE(15:0/20:0), we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PE(15:0/20:0)?

PE(15:0/20:0) is suspected in Infection, CONE-ROD DYSTROPHY 1 (disorder), Diabetes, Obesity, Malaria, Atherosclerosis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PE(15:0/20:0)

MeSH term MeSH ID Detail
Activated Protein C Resistance D020016 1 associated lipids
Hamartoma Syndrome, Multiple D006223 1 associated lipids
Sneddon Syndrome D018860 1 associated lipids
Venous Thromboembolism D054556 2 associated lipids
Barth Syndrome D056889 3 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Chondrodysplasia Punctata, Rhizomelic D018902 4 associated lipids
Abortion, Habitual D000026 5 associated lipids
Trypanosomiasis D014352 5 associated lipids
Galactosemias D005693 5 associated lipids
Hyperhomocysteinemia D020138 6 associated lipids
Trematode Infections D014201 8 associated lipids
Tangier Disease D013631 8 associated lipids
Bacteremia D016470 9 associated lipids
Toxoplasmosis D014123 9 associated lipids
Thinness D013851 11 associated lipids
Fatty Liver, Alcoholic D005235 11 associated lipids
Myocardial Ischemia D017202 11 associated lipids
Iron Overload D019190 11 associated lipids
Venous Thrombosis D020246 11 associated lipids
Per page 10 20 50 | Total 42

PubChem Associated disorders and diseases

What pathways are associated with PE(15:0/20:0)

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PE(15:0/20:0)?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PE(15:0/20:0)?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PE(15:0/20:0)?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PE(15:0/20:0)?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PE(15:0/20:0)?

Knock-out

Knock-out are used in the study 'Sequential synthesis and methylation of phosphatidylethanolamine promote lipid droplet biosynthesis and stability in tissue culture and in vivo.' (Hörl G et al., 2011) and Knock-out are used in the study 'An Atg4B mutant hampers the lipidation of LC3 paralogues and causes defects in autophagosome closure.' (Fujita N et al., 2008).

Cancer Model

Cancer Model are used in the study 'Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin.' (Tang N et al., 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PE(15:0/20:0)

Download all related citations
Per page 10 20 50 100 | Total 1374
Authors Title Published Journal PubMed Link
Jumpsen JA et al. Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis. 2006 J. Cyst. Fibros. pmid:16507353
Carmieli R et al. Utilizing ESEEM spectroscopy to locate the position of specific regions of membrane-active peptides within model membranes. 2006 Biophys. J. pmid:16258052
Hamai C et al. Effect of average phospholipid curvature on supported bilayer formation on glass by vesicle fusion. 2006 Biophys. J. pmid:16299084
Sou YS et al. Phosphatidylserine in addition to phosphatidylethanolamine is an in vitro target of the mammalian Atg8 modifiers, LC3, GABARAP, and GATE-16. 2006 J. Biol. Chem. pmid:16303767
Lins L et al. "De novo" design of peptides with specific lipid-binding properties. 2006 Biophys. J. pmid:16275638
Jin JK et al. Phospholipase D1 is up-regulated in the mitochondrial fraction from the brains of Alzheimer's disease patients. 2006 Neurosci. Lett. pmid:16973278
Hicks AM et al. Unique molecular signatures of glycerophospholipid species in different rat tissues analyzed by tandem mass spectrometry. 2006 Biochim. Biophys. Acta pmid:16860597
Tseng M et al. Amycolatopsis taiwanensis sp. nov., from soil. 2006 Int. J. Syst. Evol. Microbiol. pmid:16902013
Tsuda T et al. Effect of phosphatidylcholine, phosphatidylethanolamine and lysophosphatidylcholine on the protein C/protein S anticoagulation system. 2006 Blood Coagul. Fibrinolysis pmid:16905948
Tsuda T et al. Effect of phosphatidylcholine, phosphatidylethanolamine and lysophosphatidylcholine on the activated factor X-prothrombin system. 2006 Blood Coagul. Fibrinolysis pmid:16905950
Gardiner C et al. Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay. 2006 Blood Coagul. Fibrinolysis pmid:16905952
Welsh D et al. Differential temperature acclimatization responses in the membrane phospholipids of Posthodiplostomum minimum and its second intermediate host, Lepomis macrochirus. 2006 J. Parasitol. pmid:16995394
Besson N et al. Selective incorporation of docosahexaenoic acid into lysobisphosphatidic acid in cultured THP-1 macrophages. 2006 Lipids pmid:17707985
Oberfeld B et al. Phospholipids occupy the internal lumen of the c ring of the ATP synthase of Escherichia coli. 2006 Biochemistry pmid:16460030
Wachtel E et al. A product of ozonolysis of cholesterol alters the biophysical properties of phosphatidylethanolamine membranes. 2006 Biochemistry pmid:16430232
Shizuka M et al. Synthesis of isoprostanyl phosphatidylcholine and isoprostanyl phosphatidylethanolamine. 2006 J. Org. Chem. pmid:16468779
Higuchi O et al. Aminophospholipid glycation and its inhibitor screening system: a new role of pyridoxal 5'-phosphate as the inhibitor. 2006 J. Lipid Res. pmid:16470027
Blois A et al. Interactions of chromogranin A-derived vasostatins and monolayers of phosphatidylserine, phosphatidylcholine and phosphatidylethanolamine. 2006 Regul. Pept. pmid:16445995
Alder-Baerens N et al. Loss of P4 ATPases Drs2p and Dnf3p disrupts aminophospholipid transport and asymmetry in yeast post-Golgi secretory vesicles. 2006 Mol. Biol. Cell pmid:16452632
Min Y et al. A distinctive fatty acid profile in circulating lipids of Korean gestational diabetics: a pilot study. 2006 Diabetes Res. Clin. Pract. pmid:16455150
Tosch W et al. Molecular species of phosphatidylethanolamine from continuous cultures of Saccharomyces pastorianus syn. carlsbergensis strains. 2006 Yeast pmid:16491465
Arnt L et al. Membrane activity of biomimetic facially amphiphilic antibiotics. 2006 J Phys Chem B pmid:16494408
Bakken AM et al. Glycerophospholipid molecular species in platelets and brain tissues - are platelets a good model for neurons? 2006 Platelets pmid:17074725
Mima J et al. Specific membrane binding of the carboxypeptidase Y inhibitor I(C), a phosphatidylethanolamine-binding protein family member. 2006 FEBS J. pmid:17076703
Li LO et al. Overexpression of rat long chain acyl-coa synthetase 1 alters fatty acid metabolism in rat primary hepatocytes. 2006 J. Biol. Chem. pmid:17028193
Kume H et al. Serum ethanolamine and hepatocyte proliferation in perinatal and partially hepatectomized rats. 2006 Life Sci. pmid:16872638
Salas JJ et al. Phospholipid molecular profiles in the seed kernel from different sunflower (Helianthus annuus) mutants. 2006 Lipids pmid:17120935
Moon TC et al. Ochnaflavone, naturally occurring biflavonoid, inhibits phospholipase A2 dependent phosphatidylethanolamine degradation in a CCl4-induced rat liver microsome. 2006 Biol. Pharm. Bull. pmid:17142963
Li Z et al. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. 2006 Cell Metab. pmid:16679290
Sternin E et al. Changes in molecular order across the lamellar-to-inverted hexagonal phase transition depend on the position of the double-bond in mono-unsaturated phospholipid dispersions. 2006 Chem. Phys. Lipids pmid:16574088
Buzón V and Cladera J Effect of cholesterol on the interaction of the HIV GP41 fusion peptide with model membranes. Importance of the membrane dipole potential. 2006 Biochemistry pmid:17176099
Mizushima N [Methods for monitoring macroautophagy]. 2006 Tanpakushitsu Kakusan Koso pmid:16922435
Mudgil P et al. Adsorption of lysozyme to phospholipid and meibomian lipid monolayer films. 2006 Colloids Surf B Biointerfaces pmid:16530395
Hirche F et al. Effect of dietary methionine on plasma and liver cholesterol concentrations in rats and expression of hepatic genes involved in cholesterol metabolism. 2006 Br. J. Nutr. pmid:16611377
Kume H and Sasaki H Ethanolamine modulates DNA synthesis through epidermal growth factor receptor in rat primary hepatocytes. 2006 Jan-Feb In Vitro Cell. Dev. Biol. Anim. pmid:16618207
Sawant RM et al. "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. 2006 Jul-Aug Bioconjug. Chem. pmid:16848401
Dubielecka PM et al. Mitoxantrone changes spectrin-aminophospholipid interactions. 2006 May-Jun Mol. Membr. Biol. pmid:16785207
Wen Z and Kim HY Inhibition of phosphatidylserine biosynthesis in developing rat brain by maternal exposure to ethanol. 2007 J. Neurosci. Res. pmid:17387686
Song Y et al. Rapid ambient mass spectrometric profiling of intact, untreated bacteria using desorption electrospray ionization. 2007 Chem. Commun. (Camb.) pmid:17279261
Sato T et al. Poly(ethylene glycol)-conjugated phospholipids in aqueous micellar solutions: hydration, static structure, and interparticle interactions. 2007 J Phys Chem B pmid:17286354
Li D et al. Seasonal variations of lipid content and composition in Perna viridis. 2007 Lipids pmid:17576610
Sanmarco M et al. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies. 2007 Thromb. Haemost. pmid:17549297
Tang N et al. Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. 2007 J. Natl. Cancer Inst. pmid:17596572
Epand RF et al. Bacterial lipid composition and the antimicrobial efficacy of cationic steroid compounds (Ceragenins). 2007 Biochim. Biophys. Acta pmid:17599802
Murphy SC et al. Cytoplasmic remodeling of erythrocyte raft lipids during infection by the human malaria parasite Plasmodium falciparum. 2007 Blood pmid:17526861
Li D et al. Inactivation of ras and changes of mitochondrial membrane potential contribute to oridonin-induced autophagy in a431 cells. 2007 J. Pharmacol. Sci. pmid:17895587
Madeja Z et al. New cationic polyprenyl derivative proposed as a lipofecting agent. 2007 Acta Biochim. Pol. pmid:18066397
Goss R et al. Lipid dependence of diadinoxanthin solubilization and de-epoxidation in artificial membrane systems resembling the lipid composition of the natural thylakoid membrane. 2007 Biochim. Biophys. Acta pmid:16843433
Horibata Y and Hirabayashi Y Identification and characterization of human ethanolaminephosphotransferase1. 2007 J. Lipid Res. pmid:17132865
Baronas ET et al. Biomarkers to monitor drug-induced phospholipidosis. 2007 Toxicol. Appl. Pharmacol. pmid:17156806